Sun Pharmaceutical Industries Ltd receives warning letter from USFDA for Dadra facility

Sun Pharmaceutical Industries Limited has received Warning Letter from USFDA for its Dadra facility. The Warning Letter summarizes violations with respect to Current Good Manufacturing Practice (cGMP) regulations. The contents of the Warning Letter shall be made public by the USFDA in due course.

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1504.15 as compared to the previous close of Rs. 1520.65. The total number of shares traded during the day was 39453 in over 2525 trades.

The stock hit an intraday high of Rs. 1530.00 and intraday low of 1500.25. The net turnover during the day was Rs. 59802167.00.

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries INE044A01036 USFDA WarningLetter DadraFacility